Type 2 diabetes and pre-diabetic abnormalities in patients with bipolar disorders

Journal of Affective Disorders

Volumn 189, Issue , 2016, Pages 240-245

  Leopold, Karolina ^a   Reif, Andreas ^b,c   Haack, Sarah ^a   Bauer, Michael ^a   Bury, Daniel ^b   Löffler, Antje ^a   Kittel Schneider, Sarah ^b,c   Pfeiffer, Steffi ^a   Sauer, Cathrin ^a   Schwarz, Peter ^a   Pfennig, Andrea ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Bipolar disorder; Diabetes; Glucose; Metabolic; Pre diabetes

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GHRELIN; LEPTIN; LITHIUM; OLANZAPINE; QUETIAPINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIPOLAR DISORDER; BODY MASS; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; GLOBAL ASSESSMENT OF FUNCTIONING; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT CARE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCREENING TEST; SHORT FORM 12; UNIVERSITY HOSPITAL; YOUNG MANIA RATING SCALE; AGED; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PREDIABETIC STATE; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84943564478     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.09.041     Document Type: Article

References (46)

1. American Diabetes Association. 2006. Diagnosis and classification of diabetes mellitus. Diabetes Care 29, S43-48
2. P. Bech, C. Gudex, and K.S. Johansen The WHO (Ten) Well-Being Index: validation in diabetes Psychother. Psychosom. 65 4 1996 183 190
3. F. Benedetti, B. Barbini, C. Colombo, and E. Smeraldi Chronotherapeutics in a psychiatric ward Sleep Med. Rev. 11 6 2007 509 522
4. A.B. Birkenaes, S. Opjordsmoen, C. Brunborg, J.A. Engh, H. Jonsdottir, P.A. Ringen, C. Simonsen, A. Vaskinn, K.I. Birkeland, S. Friis, K. Sundet, and O.A. Andreassen The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study J. Clin. Psychiatry 68 6 2007 917 923
5. C.V. Calkin, D.M. Gardner, T. Ransom, and M. Alda The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders Ann. Med. 45 2 2013 171 181
6. C.V. Calkin, M. Ruzickova, R. Uher, T. Hajek, C.M. Slaney, J.S. Garnham, M.C. O'Donovan, and M. Alda Insulin resistance and outcome in bipolar disorder Br. J. Psychiatry 206 1 2015 52 57
7. F.P. Cappuccio, L. D'Elia, P. Strazzullo, and M.A. Miller Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies Sleep 33 5 2010 585 592
8. C.P. Carney, L. Jones, and R.F. Woolson Medical comorbidity in women and men with schizophrenia: a population-based controlled study J Gen Intern Med. 21 11 2006 1133 1137
9. F. Cassidy, E. Ahearn, and B.J. Carroll Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients Am. J. Psychiatry 156 9 1999 1417 1420
10. R. Castilla-Puentes Effects of psychotropics on glycosylated hemoglobin (HbA1c) in a cohort of bipolar patients Bipolar. Disord. 9 7 2007 772 778
11. N. Chakarova, T. Tankova, I. Atanassova, and L. Dakovska Serum lipid and hsCRP levels in prediabetes - impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) Diabetes Res. Clin. Pract. 86 1 2009 56 60
12. C. Crump, K. Sundquist, M.A. Winkleby, and J. Sundquist Comorbidities and mortality in bipolar disorder: a Swedish national cohort study JAMA Psychiatry 70 9 2013 931 939
13. P.K. de Barros, O.C.L. de, K.I. Silval, V.V. Dias, M.C. Roso, M. Bandeira, F. Colom, and R.A. Moreno Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder Acta Psychiatr. Scand. 127 2 2013 153 158
14. M. De Hert, J.M. Dekker, D. Wood, K.G. Kahl, R.I. Holt, and H.J. Moller Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) Eur. Psychiatry 24 2009 412 424
15. J.L. Elmslie, J.I. Mann, J.T. Silverstone, S.M. Williams, and S.E. Romans Determinants of overweight and obesity in patients with bipolar disorder J. Clin. Psychiatry 62 6 2001 486 491
16. J.J. Guo, P.E., Jr Keck, P.K. Corey-Lisle, H. Li, D. Jiang, R. Jang, and G.J. L'Italien Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: a retrospective, population-based, case-control study J. Clin. Psychiatry 67 7 2006 1055 1061
17. P. Hollander, and C. Spellman Controversies in prediabetes: do we have a diagnosis? Postgrad. Med. 124 4 2012 109 118
18. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels:IDF, 2005
19. S.H. Jones, G. Thornicroft, M. Coffey, and G. Dunn A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF) Br. J. Psychiatry 166 5 1995 654 659
20. L.V. Kessing, F.M. Nilsson, V. Siersma, and P.K. Andersen No increased risk of developing depression in diabetes compared to other chronic illness Diabetes Res. Clin. Pract. 62 2 2003 113 121
21. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, and D.M. Nathan Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N. Engl. J. Med. 346 6 2002 393 403
22. S.L. Lilliker Prevalence of diabetes in a manic-depressive population Compr. Psychiatry 21 4 1980 270 275
23. G. Mammen, and G. Faulkner Physical activity and the prevention of depression: a systematic review of prospective studies Am. J. Prev. Med. 45 5 2013 649 657
24. P. Manu, C.U. Correll, W.R. van, M. Wampers, and H.M. De Prediabetes in patients treated with antipsychotic drugs J. Clin. Psychiatry 73 4 2012 460 466
25. P. Manu, C.U. Correll, M. Wampers, W.R. van, W. Yu, D. Shiffeldrim, and H.M. De Dysmetabolic features of the overweight patients receiving antipsychotic drugs: a comparison with normal weight and obese subjects Eur. Psychiatry 29 3 2014 179 182
26. R.S. McIntyre, J.Z. Konarski, V.L. Misener, and S.H. Kennedy Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications Ann. Clin. Psychiatry 17 2 2005 83 93
27. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br. J. Psychiatry 134 1979 382 389
28. G. Muller, J. Olschewski, T. Stange, V.T. Hjellset, S. Bornstein, and P.E. Schwarz Non-invasive screening of diabetes risk by assessing abnormalities of sudomotor function Exp. Clin. Endocrinol. Diabetes. 123 2014 34 38
29. U. Osby, L. Brandt, N. Correia, A. Ekbom, and P. Sparen Excess mortality in bipolar and unipolar disorder in Sweden Arch. Gen. Psychiatry 58 9 2001 844 850
30. A. Pfennig, T. Bschor, T. Baghai, P. Braunig, P. Brieger, P. Falkai, D. Geissler, R. Gielen, H. Giesler, O. Gruber, I. Kopp, T.D. Meyer, K.H. Mohrmann, C. Muche-Borowski, F. Padberg, H. Scherk, D. Strech, and M. Bauer [S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations] Nervenarzt 83 5 2012 568 586
31. M. Pibernik-Okanovic, D. Begic, D. Ajdukovic, N. Andrijasevic, and Z. Metelko Psychoeducation versus treatment as usual in diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial Trials 10 2009 78
32. D.T. Plante, and J.W. Winkelman Sleep disturbance in bipolar disorder: therapeutic implications Am. J. Psychiatry 165 7 2008 830 843
33. W.T. Regenold, R.K. Thapar, C. Marano, S. Gavirneni, and P.V. Kondapavuluru Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use J. Affect. Disord. 70 1 2002 19 26
34. P.S. Ritter, C. Marx, M. Bauer, K. Leopold, and A. Pfennig The role of disturbed sleep in the early recognition of bipolar disorder: a systematic review Bipolar. Disord. 13 3 2011 227 237
35. L.N. Robins, J.E. Helzer, J. Croughan, and K.S. Ratcliff National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity Arch. Gen. Psychiatry 38 4 1981 381 389
36. M. Ruzickova, C. Slaney, J. Garnham, and M. Alda Clinical features of bipolar disorder with and without comorbid diabetes mellitus Can. J. Psychiatry 48 7 2003 458 461
37. P.E. Schwarz [Prediabetes: high risk factor for diabetes mellitus type 2?-Successful prevention with early interventions for lifestyle modification] Dtsch. Med. Wochenschr. 137 37 2012 1788
38. P.E. Schwarz, C.J. Greaves, J. Lindstrom, T. Yates, and M.J. Davies Nonpharmacological interventions for the prevention of type 2 diabetes mellitus Nat. Rev. Endocrinol. 8 6 2012 363 373
39. P.E. Schwarz, J. Li, and S.R. Bornstein Screening for type 2 diabetes in primary care BMJ 338 2009 b973
40. M.K. Spearing, R.M. Post, G.S. Leverich, D. Brandt, and W. Nolen Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP Psychiatry Res. 73 3 1997 159 171
41. A.L. Stewart, R.D. Hays, and J.E., Jr Ware The MOS short-form general health survey. Reliability and validity in a patient population Med. Care 26 7 1988 724 735
42. A.G. Tabak, C. Herder, W. Rathmann, E.J. Brunner, and M. Kivimaki Prediabetes: a high-risk state for diabetes development Lancet 379 9833 2012 2279 2290
43. R. van Winkel, M. De Hert, D. Van Eyck, L. Hanssens, M. Wampers, A. Scheen, and J. Peuskens Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder Bipolar. Disord. 10 2 2008 342 348
44. Wittchen, H.U., Zaudig, M., Fydrich, T., 1997. Strukturiertes Klinisches Interview für DSM-IV. Göttingen: Hogrefe.
45. R.C. Young, J.T. Biggs, V.E. Ziegler, and D.A. Meyer Rating-scale for mania-reliability, validity and sensitivity Br. J. Psychiatry 133 1978 429 435
46. G. Yuan, L. Zhou, J. Tang, Y. Yang, W. Gu, F. Li, J. Hong, Y. Gu, X. Li, G. Ning, and M. Chen Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity Diabetes Res. Clin. Pract. 72 3 2006 244 250